Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/22
Trade details
- Type
- Insider sale
- Amount
- $1,278,639.18
- Shares · price
- 2,259 sh · $566.02 a share
- Held after
- 40,673 sh
- Trade date
- 26/05/21
- Filed
- 26/05/22
- Days to filing
- 1 days
Sold 5.3% of holdings
- Share of holding sold
- 5.3%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 04/21~06/20Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$220.2K
400 sh
$220.2K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$218.9K
400 sh
$218.9K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$153.5K
280 sh
$153.5K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$131.9K
240 sh
$131.9K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$114.8K
207 sh
$114.8K
Filed 10/01
Traded 09/30